Tumor necrosis factor-alpha (TNF-alpha) promotes cell survival during spermatogenesis, and this effect can be blocked by infliximab, a TNF-alpha antagonist

JS Suominen; Y Wang; A Kaipia; J Toppari

Tumor necrosis factor-alpha (TNF-alpha) promotes cell survival during spermatogenesis, and this effect can be blocked by infliximab, a TNF-alpha antagonist

JS Suominen, Y Wang, A Kaipia, J Toppari

Research output: Contribution to journal › Article › Scientific › peer-review

75 Citations (Scopus)

Original language	English
Pages (from-to)	629-640
Journal	EUROPEAN JOURNAL OF ENDOCRINOLOGY
Volume	151
Publication status	Published - 2004
Publication type	A1 Journal article-refereed

Access to Document

https://pubmed.ncbi.nlm.nih.gov/15538942

Cite this

@article{0622be14385944ca997d1ae9d9e8a59b,

title = "Tumor necrosis factor-alpha (TNF-alpha) promotes cell survival during spermatogenesis, and this effect can be blocked by infliximab, a TNF-alpha antagonist",

author = "JS Suominen and Y Wang and A Kaipia and J Toppari",

year = "2004",

language = "English",

volume = "151",

pages = "629--640",

journal = "EUROPEAN JOURNAL OF ENDOCRINOLOGY",

issn = "0804-4643",

publisher = "BioScientifica",

}

TY - JOUR

T1 - Tumor necrosis factor-alpha (TNF-alpha) promotes cell survival during spermatogenesis, and this effect can be blocked by infliximab, a TNF-alpha antagonist

AU - Suominen, JS

AU - Wang, Y

AU - Kaipia, A

AU - Toppari, J

PY - 2004

Y1 - 2004

M3 - Article

SN - 0804-4643

VL - 151

SP - 629

EP - 640

JO - EUROPEAN JOURNAL OF ENDOCRINOLOGY

JF - EUROPEAN JOURNAL OF ENDOCRINOLOGY

ER -